Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

HIV Infection

Free Subscription 02.07.2018 18 AIDS 9 AIDS Res Hum Retroviruses 1 Ann Intern Med 1 BMJ 2 Clin Infect Dis 5 HIV Med 6 J Acquir Immune Defic Syndr 1 J Immunol 1 J Infect Dis 2 J Virol 1 JAMA 5 Lancet HIV 2 MMWR Morb Mortal Wkly Rep 1 Pediatr Infect Dis J 1 PLoS Genet 1 PLoS Med 11 PLoS One 1 PLoS Pathog 2 Proc Natl Acad Sci U S A 2 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. RABKIN M, de Pinho H, Michaels-Strasser S, Naitore D, et al
   Strengthening the health workforce to support integration of HIV and noncommunicable disease services in sub-Saharan Africa.
   AIDS. 2018;32 Suppl 1:S47-S54.
   PubMed     Text format     Abstract available
   
   
2. NUGENT R, Barnabas RV, Golovaty I, Osetinsky B, et al
   Costs and cost-effectiveness of HIV/noncommunicable disease integration in Africa: from theory to practice.
   AIDS. 2018;32 Suppl 1:S83-S92.
   PubMed     Text format     Abstract available
   
   
3. JOHNSON M, Wilkinson J, Gardner A, Kupfer LE, et al
   Global partnerships to support noncommunicable disease care in low and middle-income countries: lessons from HIV/AIDS.
   AIDS. 2018;32 Suppl 1:S75-S82.
   PubMed     Text format     Abstract available
   
   
4. JUMA K, Reid M, Roy M, Vorkoper S, et al
   From HIV prevention to non-communicable disease health promotion efforts in sub-Saharan Africa: A Narrative Review.
   AIDS. 2018;32 Suppl 1:S63-S73.
   PubMed     Text format     Abstract available
   
   
5. PASTAKIA SD, Tran DN, Manji I, Wells C, et al
   Building reliable supply chains for noncommunicable disease commodities: lessons learned from HIV and evidence needs.
   AIDS. 2018;32 Suppl 1:S55-S61.
   PubMed     Text format     Abstract available
   
   
6. RABKIN M, Palma A, McNairy ML, Gachuhi AB, et al
   Integrating cardiovascular disease risk factor screening into HIV services in Swaziland: lessons from an implementation science study.
   AIDS. 2018;32 Suppl 1:S43-S46.
   PubMed     Text format     Abstract available
   
   
7. NJUGUNA B, Vorkoper S, Patel P, Reid MJA, et al
   Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps.
   AIDS. 2018;32 Suppl 1:S33-S42.
   PubMed     Text format     Abstract available
   
   
8. MATANJE MWAGOMBA BL, Ameh S, Bongomin P, Juma PA, et al
   Opportunities and challenges for evidence-informed HIV-noncommunicable disease integrated care policies and programs: lessons from Malawi, South Africa, Swaziland and Kenya.
   AIDS. 2018;32 Suppl 1:S21-S32.
   PubMed     Text format     Abstract available
   
   
9. PATEL P, Rose CE, Collins PY, Nuche-Berenguer B, et al
   Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.
   AIDS. 2018;32 Suppl 1:S5-S20.
   PubMed     Text format     Abstract available
   
   
10. EL-SADR WM, Goosby E
    Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV.
    AIDS. 2018;32 Suppl 1:S1-S3.
    PubMed     Text format     Abstract available
    
    
11. GRAYHACK C, Sheth A, Kirby O, Davis J, et al
    Evaluating outcomes of mother-infants pairs using dolutegravir for HIV treatment during pregnancy.
    AIDS. 2018 Jun 25. doi: 10.1097/QAD.0000000000001931.
    PubMed     Text format     Abstract available
    
    
12. KEMP CG, Weiner BJ, Sherr KH, Kupfer LE, et al
    Implementation science for integration of HIV and non-communicable disease services in sub-Saharan Africa: a systematic review.
    AIDS. 2018;32 Suppl 1:S93-S105.
    PubMed     Text format     Abstract available
    
    
13. VORKOPER S, Kupfer LE, Anand N, Patel P, et al
    Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda.
    AIDS. 2018;32 Suppl 1:S107-S113.
    PubMed     Text format     Abstract available
    
    
14. MONTGOMERY ET, Stadler J, Naidoo S, Katz AWK, et al
    Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.
    AIDS. 2018;32:1517-1525.
    PubMed     Text format     Abstract available
    
    
15. LACOMBE K
    Risk of hepatocellular carcinoma after DAA treatment in cirrhotic HIV-HCV-coinfected patients: where do we stand?
    AIDS. 2018;32:1533-1534.
    PubMed     Text format    
    
    
16. SCHMIDT B
    The Fab-ulous IgM in neutralizing HIV-1.
    AIDS. 2018;32:1535-1536.
    PubMed     Text format    
    
    
17. SARAIYA N, Kanagala V, Corpuz M
    HIV-2 in the United States: rare but not forgotten.
    AIDS. 2018;32:1547-1549.
    PubMed     Text format    
    
    
18. MENDOZA MCB, Gardner L, Armon C, Rose C, et al
    Time spent with HIV viral load >1500 copies/mL among patients in HIV care, 2000-2014.
    AIDS. 2018 Jun 28. doi: 10.1097/QAD.0000000000001921.
    PubMed     Text format     Abstract available
    
    

    
    AIDS Res Hum Retroviruses

19. TARIQ U, Parveen A, Akhtar F, Mahmood F, et al
    Emergence of Circulating Recombinant Form 56_cpx in Pakistani HIV-infected patient.
    AIDS Res Hum Retroviruses. 2018 Jun 27. doi: 10.1089/AID.2018.0128.
    PubMed     Text format     Abstract available
    
    
20. RECORDON-PINSON P, Alves B, Tumiotto C, Bellecave P, et al
    A new HIV-1 circulating recombinant form (CRF98_cpx) between CRF06_cpx and subtype B identified in Southwestern France.
    AIDS Res Hum Retroviruses. 2018 Jun 27. doi: 10.1089/AID.2018.0122.
    PubMed     Text format     Abstract available
    
    
21. SILVA CMD, Peder LD, Jorge FA, Thomazella MV, et al
    High seroprevalence of syphilis among HIV-infected patients and predictors associated.
    AIDS Res Hum Retroviruses. 2018 Jun 26. doi: 10.1089/AID.2018.0036.
    PubMed     Text format     Abstract available
    
    
22. ARMSTRONG M, Nigh E, Gill-Wiehl G, Doblecki-Lewis S, et al
    Letter to the Editor: Medical Students' Perspectives on HIV Prevention Education in the Pre-Clinical Years.
    AIDS Res Hum Retroviruses. 2018 Jun 26. doi: 10.1089/AID.2018.0085.
    PubMed     Text format     Abstract available
    
    
23. CELLA E, Foley B, Riva E, Scolamacchia V, et al
    HIV-2 infection in a migrant from Gambia: the history of the disease combined with phylogenetic analysis revealed the real source of infection.
    AIDS Res Hum Retroviruses. 2018 Jun 28. doi: 10.1089/AID.2018.0112.
    PubMed     Text format     Abstract available
    
    
24. IZQUIERDO-USEROS N
    The Mathilde Krim effect as a way to overcome the Matilda effect.
    AIDS Res Hum Retroviruses. 2018 Jun 26. doi: 10.1089/AID.2018.0082.
    PubMed     Text format     Abstract available
    
    
25. GIANCOLA ML, Balestra P, Ammassari A, Ricottini M, et al
    Prevalence and associated factors of neurocognitive impairment in HIV-positive patients on effective efavirenz/emtricitabine/tenofovir disoproxil fumarate treatment.
    AIDS Res Hum Retroviruses. 2018 Jun 21. doi: 10.1089/AID.2018.0074.
    PubMed     Text format     Abstract available
    
    
26. BRAND RM, Siegel A, Myerski A, Metter EJ, et al
    Ranpirnase Reduces HIV-1 Infection and Associated Inflammatory Changes in a Human Colorectal Explant Model.
    AIDS Res Hum Retroviruses. 2018 Jun 25. doi: 10.1089/AID.2017.0308.
    PubMed     Text format     Abstract available
    
    
27. GROSSMAN Z, Rico SV, Cone K, Shao W, et al
    Early Presence of HIV-1 Subtype C in Washington DC.
    AIDS Res Hum Retroviruses. 2018 Jun 25. doi: 10.1089/AID.2018.0041.
    PubMed     Text format     Abstract available
    
    

    
    Ann Intern Med

28. CHANG JL, Tsai AC, Musinguzi N, Haberer JE, et al
    Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study.
    Ann Intern Med. 2018 Jun 26. pii: 2686096. doi: 10.7326/M17-2252.
    PubMed     Text format     Abstract available
    
    

    
    BMJ

29. DYER C
    Doctor who hid his HIV status for fear of stigma gets suspended sentence.
    BMJ. 2018;361:k2782.
    PubMed     Text format    
    
    

    
    Clin Infect Dis

30. FULCHER JA, Du Y, Zhang TH, Sun R, et al
    Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir.
    Clin Infect Dis. 2018 Mar 21. pii: 4945456. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
31. JARVIS JN, Leeme TB, Molefi M, Chofle AA, et al
    Short Course High-dose Liposomal Amphotericin B for HIV-associated Cryptococcal Meningitis: A phase-II Randomized Controlled Trial.
    Clin Infect Dis. 2018 Jun 26. pii: 5045212. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    HIV Med

32. SAGNELLI C, Uberti-Foppa C, Hasson H, Bellini G, et al
    In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12638.
    PubMed     Text format     Abstract available
    
    
33. SCULIER D, Doco-Lecompte T, Yerly S, Metzner KJ, et al
    Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12626.
    PubMed     Text format     Abstract available
    
    
34. ROSSETTI B, Di Giambenedetto S, Torti C, Postorino MC, et al
    Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12640.
    PubMed     Text format     Abstract available
    
    
35. FABBRI G, Mastrorosa I, Vergori A, Timelli L, et al
    Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus-coinfected patients treated with direct-acting antivirals.
    HIV Med. 2018 Jun 28. doi: 10.1111/hiv.12632.
    PubMed     Text format     Abstract available
    
    
36. CASADO JL, Santiuste C, Vivancos MJ, Monsalvo M, et al
    Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.
    HIV Med. 2018 Jun 22. doi: 10.1111/hiv.12630.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

37. SHARMA A, Ma Y, Tien PC, Scherzer R, et al
    HIV Infection Is Associated With Abnormal Bone Microarchitecture: Measurement of Trabecular Bone Score in the Women's Interagency HIV Study.
    J Acquir Immune Defic Syndr. 2018;78:441-449.
    PubMed     Text format     Abstract available
    
    
38. PASQUALE DK, Doherty IA, Sampson LA, Hue S, et al
    Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks.
    J Acquir Immune Defic Syndr. 2018;78:367-375.
    PubMed     Text format     Abstract available
    
    
39. BRANSTROM R, Pachankis JE
    Validating the Syndemic Threat Surrounding Sexual Minority Men's Health in a Population-Based Study With National Registry Linkage and a Heterosexual Comparison.
    J Acquir Immune Defic Syndr. 2018;78:376-382.
    PubMed     Text format     Abstract available
    
    
40. CHIAPPINI E, Galli L, Lisi C, Gabiano C, et al
    Strategies for prevention of mother-to-child transmission adopted in the "real world" setting: data from the Italian Register for HIV-1 infection in children.
    J Acquir Immune Defic Syndr. 2018 Jun 26. doi: 10.1097/QAI.0000000000001774.
    PubMed     Text format     Abstract available
    
    
41. TAGARRO A, Chan M, Zangari P, Ferns B, et al
    Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children.
    J Acquir Immune Defic Syndr. 2018 Jun 26. doi: 10.1097/QAI.0000000000001789.
    PubMed     Text format     Abstract available
    
    
42. PAUL RH, Cooley SA, Garcia-Egan PM, Ances BM, et al
    Cognitive Performance and Frailty in Older HIV-Positive Adults.
    J Acquir Immune Defic Syndr. 2018 Jun 26. doi: 10.1097/QAI.0000000000001790.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

43. PORICHIS F, Hart MG, Massa A, Everett HL, et al
    Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
    J Immunol. 2018 Jun 22. pii: jimmunol.1701551. doi: 10.4049/jimmunol.1701551.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

44. RAMJEE G, Dassaye R, Reddy T, Wand H, et al
    Targeted pregnancy and HIV prevention risk-reduction counselling for young women: lessons learned from biomedical prevention trials.
    J Infect Dis. 2018 Jun 26. pii: 5045583. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

45. DITSE Z, Muenchhoff M, Adland E, Jooste P, et al
    HIV-1 SUBTYPE C INFECTED CHILDREN WITH EXCEPTIONAL NEUTRALIZATION BREADTH EXHIBIT POLYCLONAL RESPONSES TARGETING KNOWN EPITOPES.
    J Virol. 2018 Jun 27. pii: JVI.00878-18. doi: 10.1128/JVI.00878.
    PubMed     Text format     Abstract available
    
    
46. SCHILLING M, Bulli L, Weigang S, Graf L, et al
    Human MxB protein is a pan-herpesvirus restriction factor.
    J Virol. 2018 Jun 27. pii: JVI.01056-18. doi: 10.1128/JVI.01056.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

47. WEJNERT C, Prejean J, Hoots B, Hall HI, et al
    Prevalence of Missed Opportunities for HIV Testing Among Persons Unaware of Their Infection.
    JAMA. 2018;319:2555-2557.
    PubMed     Text format    
    
    

    
    Lancet HIV

48. BAILEY H, Zash R, Rasi V, Thorne C, et al
    HIV treatment in pregnancy.
    Lancet HIV. 2018 Jun 26. pii: S2352-3018(18)30059.
    PubMed     Text format     Abstract available
    
    
49. WAITT C, Low N, Van de Perre P, Lyons F, et al
    Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings.
    Lancet HIV. 2018 Jun 27. pii: S2352-3018(18)30098.
    PubMed     Text format     Abstract available
    
    
50. 
    Correction to Lancet HIV 2018; 5: e270-71.
    Lancet HIV. 2018 Jun 18. pii: S2352-3018(18)30139.
    PubMed     Text format    
    
    
51. 
    Correction to Lancet HIV 2018; DOI:10.1016/S2352-3018(18)30092-4.
    Lancet HIV. 2018 Jun 22. pii: S2352-3018(18)30147.
    PubMed     Text format    
    
    
52. SUGARMAN J, Barnes M, Rose S, Dumchev K, et al
    Development and implementation of participant safety plans for international research with stigmatised populations.
    Lancet HIV. 2018 Jun 22. pii: S2352-3018(18)30073.
    PubMed     Text format     Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

53. BORISOV AS, Bamrah Morris S, Njie GJ, Winston CA, et al
    Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.
    MMWR Morb Mortal Wkly Rep. 2018;67:723-726.
    PubMed     Text format     Abstract available
    
    
54. DIEPSTRA KL, Cunningham T, Rhodes AG, Yerkes LE, et al
    Prevalence and Predictors of Provider-Initiated HIV Test Offers Among Heterosexual Persons at Increased Risk for Acquiring HIV Infection - Virginia, 2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:714-717.
    PubMed     Text format     Abstract available
    
    

    
    Pediatr Infect Dis J

55. SAID K, Hella J, Ruzegea M, Solanki R, et al
    Immunologic-Based Diagnosis of Latent Tuberculosis among Children Less Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania: Implications for Tuberculosis Infection Screening.
    Pediatr Infect Dis J. 2018 Jun 27. doi: 10.1097/INF.0000000000002131.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

56. THEYS K, Feder AF, Gelbart M, Hartl M, et al
    Within-patient mutation frequencies reveal fitness costs of CpG dinucleotides and drastic amino acid changes in HIV.
    PLoS Genet. 2018;14:e1007420.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

57. TORRONE EA, Morrison CS, Chen PL, Kwok C, et al
    Correction: Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
    PLoS Med. 2018;15:e1002608.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

58. HUSSEIN FM, Ahmed AY, Muhammed OS
    Household food insecurity access scale and dietary diversity score as a proxy indicator of nutritional status among people living with HIV/AIDS, Bahir Dar, Ethiopia, 2017.
    PLoS One. 2018;13:e0199511.
    PubMed     Text format     Abstract available
    
    
59. ROSEMARY A, Chika O, Jonathan O, Godwin I, et al
    Genotyping performance evaluation of commercially available HIV-1 drug resistance test.
    PLoS One. 2018;13:e0198246.
    PubMed     Text format     Abstract available
    
    
60. KIERTIBURANAKUL S, Wongprasit P, Phuphuakrat A, Chotiprasitsakul D, et al
    Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among partners of HIV-infected individuals in Thailand.
    PLoS One. 2018;13:e0198654.
    PubMed     Text format     Abstract available
    
    
61. YAYA S, Ghose B
    Patterns of computer and Internet use and its association with HIV knowledge in selected countries in sub-Saharan Africa.
    PLoS One. 2018;13:e0199236.
    PubMed     Text format     Abstract available
    
    
62. KHOZA SP, Crowther NJ, Bhana S
    The effect of HIV infection on glycaemia and renal function in type 2 diabetic patients.
    PLoS One. 2018;13:e0199946.
    PubMed     Text format     Abstract available
    
    
63. MBU ET, Sauter F, Zoufaly A, Bronsvoort BMC, et al
    Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
    PLoS One. 2018;13:e0199634.
    PubMed     Text format     Abstract available
    
    
64. THURMAN AR, Schwartz JL, Brache V, Clark MR, et al
    Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
    PLoS One. 2018;13:e0199778.
    PubMed     Text format     Abstract available
    
    
65. JAKUBOWSKI A, Snyman K, Kwarisiima D, Sang N, et al
    High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial.
    PLoS One. 2018;13:e0198912.
    PubMed     Text format     Abstract available
    
    
66. SHIBABAW A, Gelaw B, Wang SH, Tessema B, et al
    Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    PLoS One. 2018;13:e0198080.
    PubMed     Text format     Abstract available
    
    
67. NACHER M, Adenis A, Huber F, Hallet E, et al
    Estimation of the duration between HIV seroconversion and HIV diagnosis in different population groups in French Guiana: Strategic information to reduce the proportion of undiagnosed infections.
    PLoS One. 2018;13:e0199267.
    PubMed     Text format     Abstract available
    
    
68. BASOVA L, Najera JA, Bortell N, Wang D, et al
    Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection.
    PLoS One. 2018;13:e0199861.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Pathog

69. YACOOB C, Lange MD, Cohen K, Lathia K, et al
    B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques.
    PLoS Pathog. 2018;14:e1007120.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

70. BART SM, Cohen C, Dye JM, Shorter J, et al
    Enhancement of Ebola virus infection by seminal amyloid fibrils.
    Proc Natl Acad Sci U S A. 2018 Jun 25. pii: 1721646115.
    PubMed     Text format     Abstract available
    
    
71. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Text format     Abstract available
    
    

    
    Virology

72. BOWDER D, Hollingsead H, Durst K, Hu D, et al
    Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses.
    Virology. 2018;521:158-168.
    PubMed     Text format     Abstract available
    
    
73. GUO J, Liu X, Wu C, Hu J, et al
    The transmembrane nucleoporin Pom121 ensures efficient HIV-1 pre-integration complex nuclear import.
    Virology. 2018;521:169-174.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: